EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase III)

Secukinumab for Giant Cell Arteritis

John H Stone, Nils Venhoff, Frank Buttgereit, Christian Dejaco, Wolfgang A Schmidt, Robert Spiera, Ricardo Blanco, Andrea Rubbert-Roth, Christian Von Frenckell, Daniel Blockmans, Benjamin Terrier, Gerald Tracey und 9 weitere

NEJM Evidence · 23.06.2026 · 5 (7)

DOI: 10.1056/evidoa2600112 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift NEJM Evidence, erschienen am 23.06.2026. Verfasst von John H Stone und 20 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Giant Cell Arteritis, Antibodies, Monoclonal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Giant Cell ArteritisAntibodies, MonoclonalHumansAntibodies, Monoclonal, HumanizedDouble-Blind MethodFemaleMaleAgedGlucocorticoidsAged, 80 and overTreatment OutcomeMiddle Aged

Substanzen

Antibodies, Monoclonal, HumanizedsecukinumabAntibodies, MonoclonalGlucocorticoids

Autor:innen und Institutionen

  • Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Department of Rheumatology and Clinical Immunology, Medical Center, University of Freiburg, Freiburg, Germany.
  • Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Deutsches Rheumaforschungszentrum, ein Institut der Leibniz Gemeinschaft, Berlin, Germany.
  • Department of Rheumatology, Hospital of Brunico, Südtiroler Sanitätsbetrieb - Azienda Sanitaria dell'Alto Adige (SABES-ASAA), Teaching Hospital of the Paracelsus University, Brunico, Italy.
  • Department of Rheumatology and Immunology, Medical University of Graz, Graz, Austria.

Zitieren

APA

Stone, J. H., Venhoff, N., Buttgereit, F., Dejaco, C., Schmidt, W. A., Spiera, R., Blanco, R., Rubbert-Roth, A., Von Frenckell, C., Blockmans, D., Terrier, B., Tracey, G., Hauge, E. M., Keyport, M. P., Ng, J., Hiremath, R., Fu, R., Cho, G., Bacher, G., …, & Mendelson, M. H. (2026). Secukinumab for Giant Cell Arteritis. NEJM Evidence, 5(7). https://doi.org/10.1056/evidoa2600112

Vancouver

Stone JH, Venhoff N, Buttgereit F, Dejaco C, Schmidt WA, Spiera R, et al. Secukinumab for Giant Cell Arteritis. NEJM Evidence. 2026;5(7). doi:10.1056/evidoa2600112

BibTeX
@article{Stone2026,
  author = {Stone, John H and Venhoff, Nils and Buttgereit, Frank and Dejaco, Christian and Schmidt, Wolfgang A and Spiera, Robert and Blanco, Ricardo and Rubbert-Roth, Andrea and Von Frenckell, Christian and Blockmans, Daniel and Terrier, Benjamin and Tracey, Gerald and Hauge, Ellen Margrethe and Keyport, Monica Pastoral and Ng, Jennifer and Hiremath, Renuka and Fu, Rong and Cho, GaEun and Bacher, Gerald and Thiel, Jens and Mendelson, Meryl H},
  title = {Secukinumab for Giant Cell Arteritis},
  journal = {NEJM Evidence},
  year = {2026},
  volume = {5},
  number = {7},
  doi = {10.1056/evidoa2600112}
}
Kostenlos starten →